Another limitation is the use of TMAs instead of full tissue sections especially for the evaluation of PD-L1 expression, as previous research has demonstrated that PD-L1 expression within core biopsy material from one breast cancer patient may vary even 4-fould between fields of view [38]. This evidence concerns the gene CD274 and breast carcinoma.